PCSF successfully found the interactions between Furin–Notch receptors that regulate the Notch pathway in cancer progression where Furin, a low-degree ligand, generates biologically active heterodimer receptors (Qiu et al., 2015). The gene discussed is FURIN; the disease is cancer.